Related Experiment Video
Updated: May 14, 2026
03:53
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Does empiric therapy for atypical pathogens improve outcomes for patients with CAP?
Thomas M File1, Thomas J Marrie
1Infectious Disease Section, Department of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH 44272, USA. filet@summahealth.org
Infectious Disease Clinics of North America
|February 13, 2013
Summary
Empiric therapy for community-acquired pneumonia should include atypical pathogens. Early treatment benefits patients, and these pathogens are common, necessitating broad empiric coverage until better diagnostics are available.
Area of Science:
- Infectious Diseases
- Pulmonology
- Microbiology
Background:
- Community-acquired pneumonia (CAP) treatment guidelines debate the inclusion of atypical pathogens in empiric therapy.
- Ambiguity in terminology, diagnostic limitations, and conflicting study results contribute to this controversy.
- Atypical pathogens are increasingly recognized as significant contributors to CAP morbidity.
Purpose of the Study:
- To evaluate the clinical benefit of including atypical pathogens in empiric CAP therapy.
- To address the controversy surrounding empiric treatment of CAP.
- To provide evidence-based recommendations for CAP management.
Main Methods:
- Review of published literature on CAP treatment and pathogen prevalence.
- Analysis of studies focusing on time to clinical recovery and early therapeutic endpoints.
- Examination of surveillance data on atypical pathogen frequency in CAP.
Main Results:
- Studies indicate that timely and appropriate therapy, including coverage for atypical pathogens, improves clinical recovery.
- Evidence suggests atypical pathogens are frequently implicated in CAP cases.
- Current diagnostic methods lack the accuracy, cost-effectiveness, and ease of use for point-of-care etiologic diagnosis.
Conclusions:
- Empiric therapy for community-acquired pneumonia should encompass atypical pathogens.
- Early and appropriate treatment is crucial for patient recovery.
- Continued empiric coverage is warranted due to pathogen prevalence and diagnostic limitations.
Related Concept Videos
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications